Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Judith Trotman | Researchclopedia

Back to researchers

Judith Trotman

The University of Sydney ORCID

370

Works

11,560

Citations

46

h-index

117

i10-index

Research Topics

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Viral-associated cancers and disorders

Affiliations

Université Claude Bernard Lyon 12016–2016

University of Sydney2007–2025

Concord Hospital2008–2023

Université Paris-Est Créteil2016–2017

Concord Repatriation General Hospital2006–2025

Top Works

Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

Sally F. Barrington,N. George Mikhaeel,et al.

20141,616 citations

Acute Lymphoblastic Leukemia research

Lung Cancer Treatments and Mutations

Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma

Peter Johnson,Massimo Federico,et al.

2016779 citations

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince,Youn H. Kim,et al.

2017570 citations

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

Constantine S. Tam,Stephen Opat,et al.

2020439 citations

Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL

Constantine S. Tam,Judith Trotman,et al.

2019361 citations

Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

Meletios Α. Dimopoulos,Alessandra Tedeschi,et al.

2018346 citations

Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies

Michel Meignan,Anne‐Ségolène Cottereau,et al.

2016329 citations

First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study

Ian W. Flinn,Richard van der Jagt,et al.

2019295 citations

Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial

Meletios Α. Dimopoulos,Judith Trotman,et al.

2016233 citations